FDA to Review CV Risk With Azithromycin After NEJM Study – Medscape News

May 17, 2012 — The US Food and Drug Administration (FDA) will review a new study showing that patients taking azithromycin (Zithromax, Pfizer) face a small increased risk for sudden cardiac death compared with patients taking amoxicillin …

Leave a Reply

Your email address will not be published.

*